GlaxoSmithKline (Licensor)Renaissance Acquisition Holdings (Licensee)
GlaxoSmithKline granted Renaissance rights to market six approved dermatology drugs and three formulations of Zovirax acyclovir in the U.S.
Viamet (Research Partner)Mycoses Study Group Education and Research Consortium (Research Partner)
Viamet and MSGERC partner to discover and develop therapies to treat cryptococcal meningitis and other fungal infections
Set Email Alert